NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 213 filers reported holding NEOGENOMICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,885,000 | +11.0% | 101,272 | +3.9% | 0.02% | +13.3% |
| Q2 2021 | $4,402,000 | -4.6% | 97,473 | +1.9% | 0.02% | -25.0% |
| Q1 2021 | $4,615,000 | -4.8% | 95,686 | +6.3% | 0.02% | -4.8% |
| Q4 2020 | $4,846,000 | -11.0% | 90,004 | -39.0% | 0.02% | 0.0% |
| Q3 2020 | $5,444,000 | +92.4% | 147,567 | +61.6% | 0.02% | +50.0% |
| Q2 2020 | $2,829,000 | +145.4% | 91,309 | +118.6% | 0.01% | +100.0% |
| Q1 2020 | $1,153,000 | -23.4% | 41,768 | -18.8% | 0.01% | +40.0% |
| Q4 2019 | $1,505,000 | -47.9% | 51,451 | -61.0% | 0.01% | -50.0% |
| Q2 2019 | $2,891,000 | +1324.1% | 131,797 | +1231.7% | 0.01% | +900.0% |
| Q1 2019 | $203,000 | -37.2% | 9,897 | -53.0% | 0.00% | 0.0% |
| Q3 2018 | $323,000 | +119.7% | 21,074 | +88.1% | 0.00% | 0.0% |
| Q2 2018 | $147,000 | – | 11,201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |